Validation of the French Version of the Drooling Impact Scale in a Pediatric Cerebral Palsy Population

Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française

Status

Completed

Conditions

Drooling

Cerebral Palsy

Study type

Observational

Funder types

Other

Identifiers

NCT03986333

DROOLING

Details and patient eligibility

About

The aim of this study is to present the French translation of the Drooling Impact Scale (DIS-F) and to explore its validity, reliability and responsiveness to change in a group of children with Cerebral Palsy (CP)

Full description

Drooling in children with CP is likely underestimated and under treated. It is an over-handicap for these children, because it causes many complications and may lead to a decline in self-esteem and to social isolation, altering the quality of life for patients and families. The therapeutic arsenal for the management of drooling includes rehabilitation techniques, oral drug treatments, local treatments or surgical treatments whose effectiveness is variable. In order to evaluate the efficacy of these therapies, standardized and valid assessment tools must be used. The Drooling Impact Scale (DIS) developed by Dr. Sue Reid's team in Melbourne in 2008, shows good validity and sensitivity to change, especially after botulinum toxin injection. It is commonly used in English-speaking studies, but no validation in French is available yet.

The aim of this study is to present the French translation of the Drooling Impact Scale (DIS-F) and to explore its validity, reliability and responsiveness to change in a group of children with CP.

Enrollment

55 patients

Sex

All

Ages

4 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Cerebral palsy
Hypersialorrhea
No change in content and frequency of speech therapy for three months following baseline
At least 1 out of 2 parents must have a clear understanding of french language
Oral consent

Exclusion criteria